BHC — Bausch Health Companies Inc.
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 885590 ·
Last close
$5.40
Market Cap
$2.02B
52W High
$6.29
52W Low
$4.93
ADV30
1,670,296
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 2,524,000,000 | 1,786,000,000 | 521,000,000 | -1,423,000,000 | 24,498,000,000 | 1,299,000,000 | 25,580,000,000 |
| Dec 2025 | 2,796,000,000 | 1,998,000,000 | 829,000,000 | -112,000,000 | 26,366,000,000 | 1,309,000,000 | 25,989,000,000 |
| Sep 2025 | 2,681,000,000 | 1,931,000,000 | 636,000,000 | 179,000,000 | 26,824,000,000 | 1,308,000,000 | 26,468,000,000 |
| Jun 2025 | 2,530,000,000 | 1,766,000,000 | 457,000,000 | 148,000,000 | 27,266,000,000 | 1,727,000,000 | 27,119,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$1,419,000,000
Investing CF
$-604,000,000
Financing CF
$-696,000,000
CapEx
$-430,000,000
Dividends Paid
$0
Buybacks
—
EPS Diluted TTM
$-3.24
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-11,090,000,000
Inventory
$1,601,000,000
Receivables
$2,191,000,000
ST Investments
—
EBIT TTM
$736,000,000
Pretax Income TTM
$-940,000,000
Interest Exp TTM
$1,676,000,000
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$10,531,000,320
EBITDA
$3,614,000,128
Free Cash Flow
$1,123,500,032
Enterprise Value
$22,515,912,704
Total Cash
$1,299,000,064
Total Debt
$20,795,000,832
Shares Out
373,475,644
Trailing EPS
$-3.24
Book Value
$-5.51
ROE
—
ROA
5.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 10,266,000,000 | 2,185,000,000 | 157,000,000 | 26,366,000,000 | 25,989,000,000 | — | 1,400,000,000 |
| Dec 2024 | 9,625,000,000 | 1,854,000,000 | -46,000,000 | 26,523,000,000 | 26,845,000,000 | — | 1,597,000,000 |
| Dec 2023 | 8,757,000,000 | 1,600,000,000 | -592,000,000 | 27,350,000,000 | 27,432,000,000 | — | 1,032,000,000 |
| Dec 2022 | 8,124,000,000 | 1,391,000,000 | -225,000,000 | 25,686,000,000 | 25,426,000,000 | — | -728,000,000 |
TTM Snapshot
Revenues TTM
$8,905,000,000
NetIncome TTM
$124,000,000
OpCashFlow TTM
$0
Assets (Latest)
$26,523,000,000
Forward EPS
$4.06
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HCM | HUTCHMED (China) Ltd | $2.02B | $11.75 | — |
| TYRA | Tyra Biosciences, Inc. | $2.00B | $33.59 | — |
| TRVI | Trevi Therapeutics, Inc. | $2.04B | $14.38 | — |
| NBTX | Nanobiotix S.A. | $1.98B | $40.80 | — |
| ZLAB | Zai Lab Ltd | $2.07B | $18.45 | — |
News headlines (Yahoo Finance, 1h cache)
Oligometastatic Disease Market Analysis Report 2026-2036, Profiles of Leading Players - Dompe Farmaceutici, Bausch Health, Merck, Pfizer, and Glenmark Pharmaceuticals
2026-05-21 13:02 · Yahoo
Bausch Health Announces 2026 Annual Meeting of Shareholder Results
2026-05-19 20:15 · Yahoo
Cannabis Pharmaceuticals Business Research Report 2026: An $111.1 Billion Market by 2032 from $4.7 Billion in 2025 Featuring AbbVie, Aphria, Aurora Cannabis, Bausch Health, and Canopy Growth
2026-05-18 09:00 · Yahoo
Bausch Health to Participate in RBC Capital Markets 2026 Global Healthcare Conference
2026-05-13 11:00 · Yahoo
Bausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference
2026-05-12 20:15 · Yahoo
Why Bausch Health Companies Was Crawling Higher This Week
2026-05-01 05:29 · Yahoo
TSX up 455 Points at Midday With Healthcare, Materials, The Best Performers
2026-04-30 16:22 · Yahoo
BHC Q1 Earnings Miss Estimates, Sales Grow on Salix & Solta Strength
2026-04-30 14:51 · Yahoo
Bausch Health Companies Inc. Q1 2026 Earnings Call Summary
2026-04-30 12:30 · Yahoo
Bausch Health Companies Inc (BHC) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ...
2026-04-30 07:18 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.